About Vytrus Biotech
Vytrus Biotech is a company based in Terrassa (Spain) founded in 2009 by Albert Jane Font and Oscar Exposito Tarres.. Vytrus Biotech has raised $3.75 million across 3 funding rounds from investors including GVC Gaesco, Catalan Institute of Finance and Capital Cell. Vytrus Biotech offers products and services including Clarivine™, Baolift™, Photobiome™, and Elaya Renova™. Vytrus Biotech operates in a competitive market with competitors including Insempra, Naturex, Sophim, Beraca Natural Ingredients and Mibelle Biochemistry, among others.
- Headquarter Terrassa, Spain
- Founders Albert Jane Font, Oscar Exposito Tarres
-
Sectors
Chemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$5.24 M (USD)35as on Dec 31, 2024
-
Net Profit
$1.06 M (USD)87.36as on Dec 31, 2024
-
EBITDA
$1.81 M (USD)63.58as on Dec 31, 2024
-
Total Equity Funding
$3.75 M (USD)
in 3 rounds
-
Latest Funding Round
$2.49 M (USD), Series A
May 27, 2024
-
Investors
GVC Gaesco
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vytrus Biotech
Vytrus Biotech offers a comprehensive portfolio of products and services, including Clarivine™, Baolift™, Photobiome™, and Elaya Renova™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Promotes skin longevity with fasting-mimicking effects
Enhances skin firmness for a lifting effect
Protects skin microbiota from photoaging
Boosts hair anchoring and scalp regeneration
Unlock access to complete
Unlock access to complete
Funding Insights of Vytrus Biotech
Vytrus Biotech has successfully raised a total of $3.75M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.49 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $2.5M
-
First Round
First Round
(29 Oct 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series A - Vytrus Biotech | Valuation | GVC Gaesco , Catalan Institute of Finance |
|
| Sep, 2019 | Amount | Seed - Vytrus Biotech | Valuation | Catalan Institute of Finance |
|
| Oct, 2017 | Amount | Seed - Vytrus Biotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vytrus Biotech
Vytrus Biotech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include GVC Gaesco, Catalan Institute of Finance and Capital Cell. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment fund
|
Founded Year | Domain | Location | |
|
Delivers an online trading platform for accessing multiple markets efficiently.
|
Founded Year | Domain | Location | |
|
Capital Cell is recognized as a leading alternative investment platform focused on biotechnology and life sciences companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vytrus Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vytrus Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vytrus Biotech Comparisons
Competitors of Vytrus Biotech
Vytrus Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insempra, Naturex, Sophim, Beraca Natural Ingredients and Mibelle Biochemistry, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sustainable ingredients and materials for biotechnology are manufactured.
|
|
| domain | founded_year | HQ Location |
Natural extracts are manufactured for colorings, flavorings, and nutraceuticals.
|
|
| domain | founded_year | HQ Location |
Manufacturer of squalane products
|
|
| domain | founded_year | HQ Location |
Organic natural ingredients are retailed by Beraca from Brazil.
|
|
| domain | founded_year | HQ Location |
Provides innovative active ingredients for cosmetics and food health sectors globally.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vytrus Biotech
Frequently Asked Questions about Vytrus Biotech
When was Vytrus Biotech founded?
Vytrus Biotech was founded in 2009 and raised its 1st funding round 8 years after it was founded.
Where is Vytrus Biotech located?
Vytrus Biotech is headquartered in Terrassa, Spain. It is registered at Terrassa, Catalonia, Spain.
Who is the current CEO of Vytrus Biotech?
Albert Jane Font is the current CEO of Vytrus Biotech. They have also founded this company.
Is Vytrus Biotech a funded company?
Vytrus Biotech is a funded company, having raised a total of $3.75M across 3 funding rounds to date. The company's 1st funding round was a Seed of $701.12K, raised on Oct 29, 2017.
What is the annual revenue of Vytrus Biotech?
Annual revenue of Vytrus Biotech is $5.24M as on Dec 31, 2024.
What does Vytrus Biotech do?
Vytrus Biotech was founded in 2009 and is based in Terrassa, Spain. Operations focus on the biotechnology sector, where plant cell-based active ingredients for cosmetic products are developed. Various technologies, including plasma cell factors, are utilized in the production process. The company serves the cosmetics industry by providing these specialized ingredients from plant sources.
Who are the top competitors of Vytrus Biotech?
What products or services does Vytrus Biotech offer?
Vytrus Biotech offers Clarivine™, Baolift™, Photobiome™, and Elaya Renova™.
Who are Vytrus Biotech's investors?
Vytrus Biotech has 3 investors. Key investors include GVC Gaesco, Catalan Institute of Finance, and Capital Cell.